Error: Could not add to watchlist. X

CF Equities HAIG - Pharma

+ Watchlist
CFEQPHB:LX
77.88
EUR
0.53
0.68%
As of 00:59:30 ET on 08/31/2015.
Fund Type
FCP
52Wk Range
70.68 - 93.04
1 Yr Return
0.23%
YTD Return
4.96%
Previous Close
78.41
52Wk Range
70.68 - 93.04
1 Yr Return
0.23%
YTD Return
4.96%
Fund Type
FCP
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 08/31/2015)
77.88
Total Assets (m EUR) (on 08/31/2015)
4.344
Inception Date
08/18/1999
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.00%
Expense Ratio
3.06%
Top Fund Holdings
Name Position Value % of Fund
M4E AG 154.04 k 466.60 k 9.74
Burcon NutraScience Corp 221.26 k 455.33 k 9.51
4SC AG 71.19 k 291.89 k 6.09
SYMTEX 8 12/03/18 322.00 287.24 k 6.00
US DOLLAR SPOT 293.33 268.53 k 5.61
Erytech Pharma SA 7.00 k 249.76 k 5.21
Epigenomics AG 39.09 k 219.88 k 4.59
Biofrontera AG 100.00 k 219.70 k 4.59
MorphoSys AG 3.00 k 216.78 k 4.53
Formycon AG 7.00 k 202.23 k 4.22
Profile
CF Equities HAIG - Pharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve the highest possible growth with its invested capital. The Fund invests primarily in equities of companies within the health industry. Pharmaceuticals, Health Services, Biotech, and the production of drugs are all possible sectors to be invested in worldwide.
ADDRESS
Hauck & Aufhaeuser Inves Gesell SA
21, Avenue de la Liberte
L-1931 Luxembourg
Luxembourg
PHONE
Tel +352 45 13 14 500